Katharina Endres

510 total citations
16 papers, 388 citations indexed

About

Katharina Endres is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Katharina Endres has authored 16 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Katharina Endres's work include Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Katharina Endres is often cited by papers focused on Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Katharina Endres collaborates with scholars based in United States, Germany and Switzerland. Katharina Endres's co-authors include L. Kung, Najju Ranjit, R.J. Treacher, Maximilian Cohen, J. L. Glancey, Winston P. Smith, Ekkehard Haen, Christoph Hiemke, Michael Paulzen and Georgios Schoretsanitis and has published in prestigious journals such as Journal of Dairy Science, Journal of Animal Science and Clinical Pharmacokinetics.

In The Last Decade

Katharina Endres

15 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Endres United States 7 229 76 70 51 50 16 388
Jan Thomas Schonewille Netherlands 12 228 1.0× 74 1.0× 60 0.9× 62 1.2× 61 1.2× 26 378
Mirko Cattani Italy 13 333 1.5× 107 1.4× 63 0.9× 54 1.1× 59 1.2× 26 423
Felicity Jackson New Zealand 9 219 1.0× 106 1.4× 88 1.3× 58 1.1× 38 0.8× 11 451
Masaaki Hanada Japan 13 210 0.9× 55 0.7× 78 1.1× 75 1.5× 47 0.9× 52 421
M.M. El-Adawy Egypt 8 282 1.2× 136 1.8× 102 1.5× 42 0.8× 42 0.8× 21 389
P. Homolka Czechia 13 408 1.8× 105 1.4× 90 1.3× 64 1.3× 109 2.2× 48 521
A. Revello‐Chion Italy 9 232 1.0× 138 1.8× 54 0.8× 80 1.6× 47 0.9× 15 380
Z. A. Jelan Malaysia 12 217 0.9× 88 1.2× 66 0.9× 30 0.6× 74 1.5× 38 373
Lifeng Dong China 10 215 0.9× 78 1.0× 53 0.8× 36 0.7× 49 1.0× 25 319
Duanqin Wu China 12 202 0.9× 62 0.8× 73 1.0× 57 1.1× 43 0.9× 35 404

Countries citing papers authored by Katharina Endres

Since Specialization
Citations

This map shows the geographic impact of Katharina Endres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Endres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Endres more than expected).

Fields of papers citing papers by Katharina Endres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Endres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Endres. The network helps show where Katharina Endres may publish in the future.

Co-authorship network of co-authors of Katharina Endres

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Endres. A scholar is included among the top collaborators of Katharina Endres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Endres. Katharina Endres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Haen, Ekkehard, et al.. (2024). Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic Drug Monitoring. 46(2). 246–251. 3 indexed citations
2.
Gaebler, Arnim Johannes, Ekkehard Haen, Katharina Endres, et al.. (2023). Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia. Pharmacology Research & Perspectives. 11(2). e01065–e01065. 2 indexed citations
3.
Schoretsanitis, Georgios, Ekkehard Haen, Daria Piacentino, et al.. (2021). Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database. European Archives of Psychiatry and Clinical Neuroscience. 271(8). 1437–1443. 4 indexed citations
4.
Haen, Ekkehard, et al.. (2021). Nebenwirkungen und Interaktionen von Neuropsychopharmaka. NeuroTransmitter. 32(1-2). 50–59. 2 indexed citations
5.
Schoretsanitis, Georgios, Ekkehard Haen, Daria Piacentino, et al.. (2021). Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions. Clinical Pharmacokinetics. 60(12). 1583–1589. 1 indexed citations
6.
Schoretsanitis, Georgios, Ekkehard Haen, Daria Piacentino, et al.. (2021). Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitate. Expert Review of Clinical Pharmacology. 15(2). 243–249. 3 indexed citations
7.
Gaebler, Arnim Johannes, Georgios Schoretsanitis, Ekkehard Haen, et al.. (2020). Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders. British Journal of Clinical Pharmacology. 87(3). 1111–1119. 9 indexed citations
8.
Endres, Katharina, et al.. (2020). Antihypertensiva in der Psychiatrie. Der Nervenarzt. 92(5). 487–493. 1 indexed citations
9.
Schoretsanitis, Georgios, Ekkehard Haen, Gerhard Gründer, et al.. (2019). Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database. European Journal of Clinical Pharmacology. 75(8). 1109–1116. 7 indexed citations
10.
Schoretsanitis, Georgios, Ekkehard Haen, Christoph Hiemke, et al.. (2019). Pharmacokinetic correlates of venlafaxine: associated adverse reactions. European Archives of Psychiatry and Clinical Neuroscience. 269(7). 851–857. 6 indexed citations
11.
Haen, Ekkehard, Christoph Hiemke, Katharina Endres, et al.. (2019). Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine. International Clinical Psychopharmacology. 34(5). 241–246. 9 indexed citations
12.
Kung, L., et al.. (2003). Effects of 9,10 anthraquinone on ruminal fermentation, total-tract digestion, and blood metabolite concentrations in sheep1. Journal of Animal Science. 81(1). 323–328. 43 indexed citations
13.
Kung, L., et al.. (2000). The Effect of Treating Forages with Fibrolytic Enzymes on its Nutritive Value and Lactation Performance of Dairy Cows. Journal of Dairy Science. 83(1). 115–122. 141 indexed citations
14.
Kung, L., et al.. (1998). The Effect of Preservatives Based on Propionic Acid on the Fermentation and Aerobic Stability of Corn Silage and a Total Mixed Ration. Journal of Dairy Science. 81(5). 1322–1330. 123 indexed citations
15.
Smith, Winston P., et al.. (1994). Scent-Station Visits as an Index to Abundance of Raccoons: An Experimental Manipulation. Journal of Mammalogy. 75(3). 637–647. 28 indexed citations
16.
M�ller, D., et al.. (1959). R�ntgenhistoradiographische und interferenzmikroskopische Trockengewichtsuntersuchungen an Zellausstrichen. Histochemistry and Cell Biology. 1(6). 438–444. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Thomas Schonewille Breakdown of academic impact, for papers by Mirko Cattani Breakdown of academic impact, for papers by Felicity Jackson Breakdown of academic impact, for papers by Masaaki Hanada Breakdown of academic impact, for papers by M.M. El-Adawy Breakdown of academic impact, for papers by P. Homolka Breakdown of academic impact, for papers by A. Revello‐Chion Breakdown of academic impact, for papers by Z. A. Jelan Breakdown of academic impact, for papers by Lifeng Dong Breakdown of academic impact, for papers by Duanqin Wu
Rankless by CCL
2026